4.6 Article

No man is an island: Living in a disadvantaged neighborhood influences chronic pain development after motor vehicle collision

Journal

PAIN
Volume 155, Issue 10, Pages 2116-2123

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1016/j.pain.2014.07.025

Keywords

Musculoskeletal pain; Motor vehicle collision; Neighborhood effects; FKBP5; Gene-by-environment interaction

Funding

  1. National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01AR056328]
  2. National Center for Advancing Translational Sciences [1UL1TR001111-01]

Ask authors/readers for more resources

Living in a lower socioeconomic status neighborhood has been shown to alter stress system function and is associated with a number of adverse health outcomes, but its influence on musculoskeletal pain (MSP) outcomes after traumatic stress exposures such as motor vehicle collision (MVC) has not been assessed. We performed a multicenter, prospective study that enrolled 948 European-American individuals within 24 hours of MVC who were discharged home after emergency department evaluation. Follow-up evaluations were completed via telephone or Internet survey 6 weeks, 6 months, and 1 year after MVC on 91%, 89%, and 91% of participants, respectively. A robust aggregate measure of census tract neighborhood disadvantage was derived, and individual-level characteristics assessed included socioeconomic and demographic characteristics, pain prior to MVC, litigation status, and opioid use. MSP was assessed in the emergency department; MSP and pain interference with daily activity were assessed at 6 weeks, 6 months, and 1 year. After adjustment for individual-level factors, living in more disadvantaged neighborhoods was associated with increased MSP (P = 0.0009) and increased pain interference with daily function (P < 0.0001). The relationship between neighborhood disadvantage and MSP was moderated by a common single nucleotide polymorphism, rs2817038, 5' of the gene encoding FKBP5, a functional regulator of glucocorticoid receptor sensitivity (interaction P-value = 0.0015). These data support the hypothesis that low neighborhood socioeconomic status increases the likelihood of worse MSP outcomes after traumatic stress exposures such as MVC, and that this influence is mediated in part via its influence on stress system function. (C) 2014 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Psychology, Clinical

Prior differences in previous trauma exposure primarily drive the observed racial/ethnic differences in posttrauma depression and anxiety following a recent trauma

N. G. Harnett, N. M. Dumornay, M. Delity, L. D. Sanchez, K. Mohiuddin, P. I. Musey, M. J. Seamon, S. A. McLean, R. C. Kessler, K. C. Koenen, F. L. Beaudoin, L. A. M. Lebois, S. J. H. van Rooij, N. A. Sampson, V Michopoulos, J. L. Maples-Keller, J. P. Haran, A. B. Storrow, C. Lewandowski, P. L. Hendry, S. Sheikh, C. W. Jones, B. E. Punches, M. C. Kurz, R. A. Swor, M. E. McGrath, L. A. Hudak, J. L. Pascual, S. L. House, X. An, J. S. Stevens, T. C. Neylan, T. Jovanovic, S. D. Linnstaedt, L. T. Germine, E. M. Datner, A. M. Chang, C. Pearson, D. A. Peak, R. C. Merchant, R. M. Domeier, N. K. Rathlev, B. J. O'Neil, P. Sergot, S. E. Bruce, M. W. Miller, R. H. Pietrzak, J. Joormann, D. M. Barch, D. A. Pizzagalli, J. F. Sheridan, J. W. Smoller, B. Luna, S. E. Harte, J. M. Elliott, K. J. Ressler

Summary: Racial and ethnic differences exist in the prevalence of posttraumatic stress disorder (PTSD) among various groups in the USA. While there are no consistent racial/ethnic differences in posttraumatic stress in the early aftermath of trauma, it appears that differences in chronic PTSD rates may be related to differences in recovery over time. In this study, racial/ethnic groups did not differ in symptoms over time, but Black participants showed reduced posttraumatic depression and anxiety symptoms compared to Hispanic and White participants. These differences in depression and anxiety were no longer significant after accounting for greater prior trauma exposure and childhood emotional abuse in White participants.

PSYCHOLOGICAL MEDICINE (2023)

Article Neurosciences

Enhancing Discovery of Genetic Variants for Posttraumatic Stress Disorder Through Integration of Quantitative Phenotypes and Trauma Exposure Information

Adam X. Maihofer, Karmel W. Choi, Jonathan R. Coleman, Nikolaos P. Daskalakis, Christy A. Denckla, Elizabeth Ketema, Rajendra A. Morey, Renato Polimanti, Andrew Ratanatharathorn, Katy Torres, Aliza P. Wingo, Clement C. Zai, Allison E. Aiello, Lynn M. Almli, Ananda B. Amstadter, Soren B. Andersen, Ole A. Andreassen, Paul A. Arbisi, Allison E. Ashley-Koch, S. Bryn Austin, Esmina Avdibegovic, Anders D. Borglum, Dragan Babic, Marie Baekvad-Hansen, Dewleen G. Baker, Jean C. Beckham, Laura J. Bierut, Jonathan Bisson, Marco P. Boks, Elizabeth A. Bolger, Bekh Bradley, Meghan Brashear, Gerome Breen, Richard A. Bryant, Angela C. Bustamante, Jonas Bybjerg-Grauholm, Joseph R. Calabrese, Jose M. Caldas-de-Almeida, Chia-Yen Chen, Anders M. Dale, Shareefa Dalvie, Jurgen Deckert, Douglas L. Delahanty, Michelle F. Dennis, Seth G. Disner, Katharina Domschke, Laramie E. Duncan, Alma Dzubur Kulenovic, Christopher R. Erbes, Alexandra Evans, Lindsay A. Farrer, Norah C. Feeny, Janine D. Flory, David Forbes, Carol E. Franz, Sandro Galea, Melanie E. Garrett, Aarti Gautam, Bizu Gelaye, Joel Gelernter, Elbert Geuze, Charles F. Gillespie, Aferdita Goci, Scott D. Gordon, Guia Guffanti, Rasha Hammamieh, Michael A. Hauser, Andrew C. Heath, Sian M. J. Hemmings, David Michael Hougaard, Miro Jakovljevic, Marti Jett, Eric Otto Johnson, Ian Jones, Tanja Jovanovic, Xue-Jun Qin, Karen-Inge Karstoft, Milissa L. Kaufman, Ronald C. Kessler, Alaptagin Khan, Nathan A. Kimbrel, Anthony P. King, Nastassja Koen, Henry R. Kranzler, William S. Kremen, Bruce R. Lawford, Lauren A. M. Lebois, Catrin Lewis, Israel Liberzon, Sarah D. Linnstaedt, Mark W. Logue, Adriana Lori, Bozo Lugonja, Jurjen J. Luykx, Michael J. Lyons, Jessica L. Maples-Keller, Charles Marmar, Nicholas G. Martin, Douglas Maurer, Matig R. Mavissakalian, Alexander McFarlane, Regina E. McGlinchey, Katie A. McLaughlin, Samuel A. McLean, Divya Mehta, Rebecca Mellor, Vasiliki Michopoulos, William Milberg, Mark W. Miller, Charles Phillip Morris, Ole Mors, Preben B. Mortensen, Elliot C. Nelson, Merete Nordentoft, Sonya B. Norman, Meaghan O'Donnell, Holly K. Orcutt, Matthew S. Panizzon, Edward S. Peters, Alan L. Peterson, Matthew Peverill, Robert H. Pietrzak, Melissa A. Polusny, John P. Rice, Victoria B. Risbrough, Andrea L. Roberts, Alex O. Rothbaum, Barbara O. Rothbaum, Peter Roy-Byrne, Kenneth J. Ruggiero, Ariane Rung, Bart P. F. Rutten, Nancy L. Saccone, Sixto E. Sanchez, Dick Schijven, Soraya Seedat, Antonia Seligowski, Julia S. Seng, Christina M. Sheerin, Derrick Silove, Alicia K. Smith, Jordan W. Smoller, Scott R. Sponheim, Dan J. Stein, Jennifer S. Stevens, Martin H. Teicher, Wesley K. Thompson, Edward Trapido, Monica Uddin, Robert J. Ursano, Leigh Luella van den Heuvel, Miranda Van Hooff, Eric Vermetten, Christiaan H. Vinkers, Joanne Voisey, Yunpeng Wang, Zhewu Wang, Thomas Werge, Michelle A. Williams, Douglas E. Williamson, Sherry Winternitz, Christiane Wolf, Erika J. Wolf, Rachel Yehuda, Keith A. Young, Ross McD Young, Hongyu Zhao, Lori A. Zoellner, Magali Haas, Heather Lasseter, Allison C. Provost, Rany M. Salem, Jonathan Sebat, Richard A. Shaffer, Tianying Wu, Stephan Ripke, Mark J. Daly, Kerry J. Ressler, Karestan C. Koenen, Murray B. Stein, Caroline M. Nievergelt

Summary: This study combines a quantitative measurement of posttraumatic stress disorder (PTSD) phenotype with lifetime trauma exposure (LTE) information to identify novel risk loci and demonstrate a high genetic overlap between PTSD and LTE.

BIOLOGICAL PSYCHIATRY (2022)

Article Clinical Neurology

Duration of Reduction in Enduring Stress-Induced Hyperalgesia Via FKBP51 Inhibition Depends on Timing of Administration Relative to Traumatic Stress Exposure

Britannia J. Wanstrath, Samuel A. McLean, Ying Zhao, Jacqueline Mickelson, Michael Bauder, Felix Hausch, Sarah D. Linnstaedt

Summary: The development of chronic pain following severe stress exposure is a frequent occurrence, and inhibiting FKBP51 may prevent it. Early administration of FKBP51 inhibitors after traumatic stress exposure shows promise in alleviating hyperalgesia.

JOURNAL OF PAIN (2022)

Article Medicine, Research & Experimental

Brief Educational Video plus Telecare to Enhance Recovery for Older Emergency Department Patients with Acute Musculoskeletal Pain: an update to the study protocol for a randomized controlled trial

Karen Hurka-Richardson, Timothy F. Platts-Mills, Samuel A. McLean, Morris Weinberger, Sally C. Stearns, Montika Bush, Eugenia Quackenbush, Srihari Chari, Aileen Aylward, Kurt Kroenke, Robert D. Kerns, Mark A. Weaver, Francis J. Keefe, David Berkoff, Michelle L. Meyer

Summary: In response to the COVID-19 pandemic, the BETTER trial made changes to its recruitment process and expanded the inclusion criteria and recruitment sites. These adjustments allowed for continued participant enrollment and resulted in operational efficiencies and increased enrollment.

TRIALS (2022)

Article Biochemistry & Molecular Biology

A cross-disorder dosage sensitivity map of the human genome

Ryan L. Collins, Joseph T. Glessner, Eleonora Porcu, Maarja Lepamets, Rhonda Brandon, Christopher Lauricella, Lide Han, Theodore Morley, Lisa-Marie Niestroj, Jacob Ulirsch, Selin Everett, Daniel P. Howrigan, Philip M. Boone, Jack Fu, Konrad J. Karczewski, Georgios Kellaris, Chelsea Lowther, Diane Lucente, Kiana Mohajeri, Margit Noukas, Xander Nuttle, Kaitlin E. Samocha, Mi Trinh, Farid Ullah, Urmo Vosa, Matthew E. Hurles, Swaroop Aradhya, Erica E. Davis, Hilary Finucane, James F. Gusella, Aura Janze, Nicholas Katsanis, Ludmila Matyakhina, Benjamin M. Neale, David Sanders, Stephanie Warren, Jennelle C. Hodge, Dennis Lal, Douglas M. Ruderfer, Jeanne Meck, Reedik Magi, Tonu Esko, Alexandre Reymond, Zoltan Kutalik, Hakon Hakonarson, Shamil Sunyaev, Harrison Brand, Michael E. Talkowski

Summary: This study aims to quantify the properties of haploinsufficiency and triplosensitivity throughout the human genome and construct a genome-wide catalog of dosage sensitivity for 54 disorders. The study identified dosage sensitive segments and developed a machine-learning model to predict probabilities of dosage sensitivity for all autosomal genes.
Article Psychology, Clinical

Derivation and validation of risk prediction for posttraumatic stress symptoms following trauma exposure

Raphael Kim, Tina Lin, Gehao Pang, Yufeng Liu, Andrew S. Tungate, Phyllis L. Hendry, Michael C. Kurz, David A. Peak, Jeffrey Jones, Niels K. Rathlev, Robert A. Swor, Robert Domeier, Marc-Anthony Velilla, Christopher Lewandowski, Elizabeth Datner, Claire Pearson, David Lee, Patricia M. Mitchell, Samuel A. McLean, Sarah D. Linnstaedt

Summary: This study utilized baseline survey data from prospective cohort studies to identify influential predictors of posttraumatic stress symptoms (PTSS) following traumatic stress exposure. The findings revealed that factors such as acute pain severity, recovery expectations, socioeconomic status, self-reported race, and psychological symptoms significantly predicted the occurrence of PTSS.

PSYCHOLOGICAL MEDICINE (2023)

Article Multidisciplinary Sciences

Rare penetrant mutations confer severe risk of common diseases

Petko P. Fiziev, Jeremy McRae, Jacob C. Ulirsch, Jacqueline S. Dron, Tobias Hamp, Yanshen Yang, Pierrick Wainschtein, Zijian Ni, Joshua G. Schraiber, Hong Gao, Dylan Cable, Yair Field, Francois Aguet, Marc Fasnacht, Ahmed Metwally, Jeffrey Rogers, Tomas Marques-Bonet, Heidi L. Rehm, Anne O'Donnell-Luria, Amit Khera, Kyle Kai-How Farh

Summary: We discovered that rare, penetrant mutations in genes associated with complex traits and common diseases have about 10-fold larger effects than common variants in the same genes. By identifying individuals at the phenotypic extreme and at risk for severe, early-onset disease through rare penetrant variants, rather than relying on many weak common variants, we greatly improve the clinical utility of genetic-based risk prediction. Our unified genetic risk model, combining rare variants across phenotype-associated genes, shows superior portability across diverse global populations compared to common-variant polygenic risk scores.

SCIENCE (2023)

Article Genetics & Heredity

Leveraging polygenic enrichments of gene features to predict genes underlying complex traits and diseases

Elle M. M. Weeks, Jacob C. C. Ulirsch, Nathan Y. Y. Cheng, Brian L. L. Trippe, Rebecca S. S. Fine, Jenkai Miao, Tejal A. A. Patwardhan, Masahiro Kanai, Joseph Nasser, Charles P. P. Fulco, Katherine C. C. Tashman, Francois Aguet, Taibo Li, Jose Ordovas-Montanes, Christopher S. S. Smillie, Moshe Biton, Alex K. K. Shalek, Ashwin N. N. Ananthakrishnan, Ramnik J. J. Xavier, Aviv Regev, Rajat M. M. Gupta, Kasper Lage, Kristin G. G. Ardlie, Joel N. N. Hirschhorn, Eric S. S. Lander, Jesse M. M. Engreitz, Hilary K. K. Finucane

Summary: Polygenic Priority Score (PoPS) integrates genome-wide association summary statistics with other data types to prioritize candidate effector genes at complex trait loci. Combining PoPS with methods that leverage local genetic signals improves performance. In this study, PoPS is introduced as a new method to prioritize genes at GWAS loci by learning trait-relevant gene features. By combining PoPS with orthogonal methods, 10,642 unique gene-trait pairs across 113 complex traits and diseases are prioritized with high precision, including both well-established gene-trait relationships and new genes at unresolved loci.

NATURE GENETICS (2023)

Article Anesthesiology

Tolerability and efficacy of duloxetine for the prevention of persistent musculoskeletal pain after trauma and injury: a pilot three-group randomized controlled trial

Francesca L. Beaudoin, Rachel Gaither, Weston C. DeLomba, Samuel A. McLean

Summary: This study investigated the tolerability and preliminary efficacy of duloxetine as a nonopioid therapeutic option for preventing persistent musculoskeletal pain after trauma or injury. The results showed that duloxetine was well tolerated in both dosage groups and there were no serious adverse events. There was a significant difference in pain over time for the 60 mg group compared to the placebo group, but not for the 30 mg group. The findings suggest that duloxetine may be a treatment option for reducing the transition from acute to persistent pain.
Meeting Abstract Neurosciences

Substance Use to Cope with Posttraumatic Stress Disorder in the Aftermath of Sexual Assault: Results From a Multi-Site Prospective Study of Women Sexual Assault Survivors

Riya Thomas, Jessie J. Ma, Nicole A. Short, Megan Lechner, Kathy Bell, Jenny Black, Jennie Buchanan, Jeffrey Ho, Ralph Riviello, Israel Liberzon, Sheila A. M. Rauch, Ronald C. Kessler, Samuel A. McLean

BIOLOGICAL PSYCHIATRY (2022)

Meeting Abstract Neurosciences

Response Inhibition Deficit as a Transdiagnostic Risk Factor for Posttraumatic Neuropsychiatric Sequelae

Sanne van Rooij, Vishnu Murty, Nathaniel Harnett, Lauren Lebois, Timothy Ely, Tanja Jovanovic, Kerry Ressler, Samuel McLean, Jennifer Stevens

BIOLOGICAL PSYCHIATRY (2022)

Meeting Abstract Neurosciences

The Impact of Childhood Maltreatment on Future PTSD Symptoms is Mediated by Internal Capsule Integrity Following Recent Trauma

Samantha Wong, Lauren A. M. Lebois, Timothy D. Ely, Sanne van Rooij, Steven E. Bruce, Vishnu P. Murty, Tanja Jovanovic, Stacey House, Samuel A. McLean, Kerry J. Ressler, Jennifer S. Stevens, Nathaniel G. Harnett

BIOLOGICAL PSYCHIATRY (2022)

Meeting Abstract Neurosciences

Understanding the Co-Emergence of PTSD and Alcohol Use: Exploring Time Since Trauma and the Role of the vmPFC

Cecilia Hinojosa, Sanne J. H. van Rooij, Nathaniel G. Harnett, Lauren A. M. Lebois, Vishnu P. Murty, Tanja Jovanovic, Stacey House, Negar Fani, Samuel A. McLean, Kerry Ressler, Jennifer Stevens

BIOLOGICAL PSYCHIATRY (2022)

Meeting Abstract Neurosciences

Risk Prediction for Posttraumatic Stress Symptoms Following Trauma Exposure

Raphael Kim, Lauren McKibben, Tina Lin, Gehao Pang, Andrew S. Tungate, Phyllis L. Hendry, Michael C. Kurz, David A. Peak, Jeffrey Jones, Niels K. Rathlev, Robert A. Swor, Robert M. Domeier, Marc-Anthony Velilla, Christopher Lewandowski, Elizabeth Datner, Claire Pearson, David C. Lee, Patricia Mitchell, Samuel A. McLean, Sarah D. Linnstaedt

BIOLOGICAL PSYCHIATRY (2022)

Meeting Abstract Neurosciences

Anxiety Sensitivity is a Leading Risk Factor of Severe or Widespread Pain Three Months After Motor Vehicle Collision

Kyle Polanco, Qinghua Li, Xinming An, Francesca Beaudoin, Donglin Zeng, Jennifer Stevens, Sarah Linnstaedt, Tanja Jovanovic, Thomas Neylan, Gari Clifford, Kerry Ressler, Karestan Koenen, Ronald Kessler, Samuel A. McLean

BIOLOGICAL PSYCHIATRY (2022)

No Data Available